Nathaniel O'Connell, Heather Shappell and Mark Espeland: Assuring COVID-19 vaccine safety | Columnists
Nathaniel OâConnell, Heather Shappell and Mark Espeland Guest columnists Last month, the Food and Drug Administration granted an emergency use authorization (EUA) for the COVID-19 vaccines produced by Pfizer-BioNTech and Moderna. With more than 35,000 volunteers receiving vaccinations across these trials, both vaccines have demonstrated significant effectiveness in protecting against COVID-19. In the coming months, these vaccines will become available to the public, but how saf...
Heather Shappell Walt Unks Nathaniel Oconnell Centers For Disease Novant Forsyth Medical Center Drug Administration
Source: journalnow.com